NCT02243631View on ClinicalTrials.gov

Effect of Probenecid on Synovial Fluid ATP Levels in CPPD

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

October 15, 2014

Primary Completion Date

April 8, 2021

Study Completion Date

April 8, 2021

Conditions
Calcium Pyrophosphate Deposition Disease
Interventions
DRUG

Probenecid

Treatment

Trial Locations (1)

53295-1000

Clement J. Zablocki VA Medical Center, Milwaukee, WI, Milwaukee

All Listed Sponsors
lead

VA Office of Research and Development

FED

NCT02243631 - Effect of Probenecid on Synovial Fluid ATP Levels in CPPD | Biotech Hunter | Biotech Hunter